arrow
arrow
arrow
Human prostate cancer cells expressing urokinase Plasminogen Activator (uPA) readily metastasize when injected into experimental animals. A scientist
Question

Human prostate cancer cells expressing urokinase Plasminogen Activator (uPA) readily metastasize when injected into experimental animals. A scientist genetically modified prostate cancer cells and injected them into experimental animals. The possible observations are listed below:
A. Overexpressing a mutant version of the uPA protein that does not bind to its receptor led to tumour formation but reduced metastasis.
B. Overexpressing a mutant version of the uPA protein that does not bind to its receptor led to enhanced tumour formation as well as metastasis.
C. Overexpressing a secreted version of the uPA receptor led to tumour formation but reduced metastasis.
D. Overexpressing a secreted version of the uPA receptor reduced tumour formation as well as metastasis.
Which of the following options represents the combination of all correct observations?

A.

A and C

B.

B and D

C.

A and D

D.

B and C

Correct option is A

Answer: A and C (option a)

Explanation


-uPA promotes invasion/metastasis by binding the cell-surface uPA receptor (uPAR) to focus proteolytic activity and trigger signaling for cell migration.
-A mutant uPA that cannot bind uPAR will not promote receptor-dependent invasion, so primary tumour formation (driven by other oncogenic events) can still occur while metastasis is reduced.
-A secreted (soluble) uPAR acts as a decoy that sequesters uPA and prevents uPA–uPAR interactions at the cell surface, so it reduces metastasis but does not necessarily block tumour formation.

Information Booster

-uPA–uPAR interaction localizes plasminogen activation to the cell surface, generating plasmin that degrades extracellular matrix and activates other proteases—key for invasion and metastasis.
-Decoy receptors or receptor-binding mutants commonly reduce invasive behaviour while leaving proliferation (tumour growth) largely unaffected unless the pathway also controls growth signals.

Additional Knowledge — why the other options are wrong

-B (mutant uPA that does not bind uPAR → enhanced tumour formation and metastasis): contradicts mechanism — loss of receptor binding should reduce invasion/metastasis, not enhance it.
-D (secreted uPAR reduces tumour formation as well as metastasis): unlikely because soluble uPAR blocks uPA-mediated invasion but typically does not eliminate primary tumour growth unless uPA–uPAR is also essential for proliferation in that model (not implied here).

Similar Questions

test-prime-package

Access ‘CSIR NET Life Sciences’ Mock Tests with

  • 60000+ Mocks and Previous Year Papers
  • Unlimited Re-Attempts
  • Personalised Report Card
  • 500% Refund on Final Selection
  • Largest Community
students-icon
383k+ students have already unlocked exclusive benefits with Test Prime!
test-prime-package

Access ‘CSIR NET Life Sciences’ Mock Tests with

  • 60000+ Mocks and Previous Year Papers
  • Unlimited Re-Attempts
  • Personalised Report Card
  • 500% Refund on Final Selection
  • Largest Community
students-icon
383k+ students have already unlocked exclusive benefits with Test Prime!
Our Plans
Monthsup-arrow